Skip to content

A prospective study on the safety and efficacy of multifocal rigid corneal contact lenses in controlling myopia

A prospective study on the safety and efficacy of multifocal rigid corneal contact lenses in controlling myopia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097623
Enrollment
Unknown
Registered
2025-02-21
Start date
2025-02-22
Completion date
Unknown
Last updated
2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ametropia

Interventions

Experimental group:Wear a rigid contact lens (Model, specification: RGP100) produced by Suzhou Gaovision HD Medical Technology Co., LTD.

Sponsors

Eye & ENT Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 11 Years

Inclusion criteria

Inclusion criteria: 1. Age 7 (inclusive) to 12 (exclusive) years old; 2. Objective optometry after ciliary paralysis SER: -0.50 to -6.00 diopter (D); 3. No myopia prevention and control measures (such as orthokeratology glasses, defocusing lenses, etc.) have been used in the past 1 month; 4. Have not used 0.01% atropine in the past 1 month or have not used other concentrations of atropine; 5. Be willing to undergo scheduled tests and follow-up visits.

Exclusion criteria

Exclusion criteria: 1.History of corneal surgery or eye surgery within the past few years; 2. Eyelid abnormalities or infection; 3. Have other active eye diseases; 4. Abnormal intraocular pressure (intraocular pressure 21mmHg or intraocular pressure difference >= 5mmHg); 5. Have a systemic condition that may affect the eyes, such as sinusitis, diabetes, Down syndrome, hyperthyroidism, rheumatoid arthritis, or other conditions that researchers consider impossible to wear rigid contact lenses; 6. Patients who need to use therapeutic eye drops, including antibiotics, mydriatic agents, corticosteroid hormones and compound eye drops containing corticosteroid hormones; 7. Cannot be worn for at least 8 hours a day and at least 6 days a week as required; 8. Can not accept the comfort of wearing RGP; 9. Suffering from other eye diseases other than fundus changes related to adolescent early onset myopia (such as pathological myopia); 10. One eye meets the inclusion criteria; 11. The researchers determined that the candidates could not be accepted.

Design outcomes

Primary

MeasureTime frame
The change of the objective optometric equivalent bulb (SER) relative to baseline length after 6 months ±14 days of cycloplegia;

Secondary

MeasureTime frame
The change of axial length of the eye from baseline at 3 months +14 months after wearing glasses;Wear satisfaction assessment;

Countries

China

Contacts

Public ContactChen Zhi

Eye & ENT Hospital of Fudan University

peter459@aliyun.com+86 21 6437 7134

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026